Riemerella anatipestifer and Escherichia coli Bivalent Vaccine, Inactivated
- Indication / Application: For the prevention of duck infectious serositis (serotype 2), duck Escherichia coli (serotype O78) and duck Pasteurella multocida (capsular type A).
- Manufacturing: Produced in GMP-certified facility
- Supply Mode: Bulk Supply / Distributor / OEM Available
- Origin: China
Generic Name
Riemerella anatipestifer and Escherichia coli Bivalent Vaccine, Inactivated
Composition and Content
| Disease | Strain | Antigen Content |
|---|---|---|
| RA | BZ | ≥ 1010 CFU/ml |
| E.coli | SG | ≥ 2.5 × 109 CFU/ml |
Appearance
After standing, the upper layer is clear with a small amount of sediment at the bottom; it becomes a uniform suspension after shaking.
Indications
For the prevention of duck infectious serositis caused by Riemerella anatipestifer serotype 2 and colibacillosis caused by Escherichia coli serotype O78. Immunity develops within 21 days and lasts for 3 months.
Dosage and Administration
Administer subcutaneously in the neck to healthy ducklings 5-7 days of age at 0.25 mL per bird.
Adverse Reactions
Generally, no adverse reactions occur.
Precautions
- 1. For immunization of healthy ducks only.
- 2. Do not freeze or expose this product to high temperatures for prolonged periods.
- 3. Allow the vaccine to reach room temperature and shake thoroughly before use.
- 4. Use the vaccine on the day the vial is opened.
- 5. Thoroughly disinfect injection equipment and the injection site before vaccination.
- 6. Properly dispose of used vaccine vials, equipment, and unused vaccine.
Specification
250 mL/bottle, 40 bottles/carton; 500 mL/bottle, 20 bottles/carton.
Storage and Shelf Life
Store at 2-8°C. Shelf life: 24 months.
